Skip to main content
Stephen Lemon, MD, Oncology, Silverdale, WA

Stephen J Lemon MD MPH

Breast Cancer, Cancer Genetics/Cancer Risk Assessment, Hematologic Oncology


Medical Oncologist - Kaiser Permanente

Join to view full profile
  • 10452 Silverdale Way NWSilverdale, WA 98383

  • Phone+1 360-307-7300

Dr. Lemon is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Stephen Lemon is a medical oncologist serving the Silverdale and Bremerton, WA area. He specializes in breast cancer, cancer genetics/cancer risk assessment, and medical oncology. After earning his B.S from Gonzaga University, he pursued an MPH at Johns Hopkins School of Public Health and completed his MD at the University of Washington School of Medicine. His further education included an internal medicine residency at Sparrow Hospital/Michigan State University and a fellowship in hematology and medical oncology at National Institutes of Health Clinical Center. He has served in various capacities including as an Assistant Professor at Creighton University School of Medicine. He has worked with the Fred Hutch Cancer Center in Bellevue, WA and is currently a medical oncologist for the Kaiser Permanente Cancer Center in Silverdale, WA. He's published several research articles and has been involved in numerous clinical trials. Over the years, he has been recognized for his contributions to medicine with awards such as the Delta Omega Honor Society in Public Health and the Alpha Omega Alpha Honor Medical Society.

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1993 - 1995
  • Johns Hopkins School of Hygiene and Public Health
    Johns Hopkins School of Hygiene and Public HealthMPH, 1991 - 1992
  • Johns Hopkins School of Hygiene and Public Health
    Johns Hopkins School of Hygiene and Public HealthMPH, 1991 - 1992
  • Johns Hopkins Bloomberg School of Public Health
    Johns Hopkins Bloomberg School of Public HealthMPH, 1991 - 1992
  • University of Michigan Health - Sparrow/Michigan State University
    University of Michigan Health - Sparrow/Michigan State UniversityResidency, Internal Medicine, 1988 - 1991

Certifications & Licensure

  • AZ State Medical License
    AZ State Medical License 2024 - 2027
  • WA State Medical License
    WA State Medical License 2005 - 2027
  • NE State Medical License
    NE State Medical License 1995 - 2021
  • IA State Medical License
    IA State Medical License 2003 - 2018
  • MD State Medical License
    MD State Medical License 1992 - 1996
  • MI State Medical License
    MI State Medical License 1988 - 1995
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Cerner Patient Portal and Powerchart, Cerner Corporation, 2013, 2015-2017
  • CMS Meaningful Use Stage 1 Certification HealthSentry, Cerner Corporation, 2013, 2015-2017
  • CMS Meaningful Use Stage 2 Certification PowerChart (CQM), Cerner Corporation, 2013, 2015-2017

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Breast Cancer Genetics 
    9/24/2009
  • Trends in Cancer Care and Treatment Options 
    4/16/2009
  • What You Should Know About Breast Cancer 
    10/1/2008

Other

  • Breast Cancer Prevention 
    Susan G, WOWT Television interview
    10/28/2008
  • Buddy check 
    Susan G, Medical Oncology Consultant, WOWT TV, monthly news segment
    1997-2001 - 12/1/2002
  • HealthWatch: Beating Cancer 
    Susan G, Medical Oncology Consultant, KETV-7 TV, weekly news segment
    6/1/1996

Press Mentions

  • Phase II Lung Cancer Clinical Trial Could Bring Another Immunotherapy Option to Mesothelioma Patients
    Phase II Lung Cancer Clinical Trial Could Bring Another Immunotherapy Option to Mesothelioma PatientsMay 26th, 2016

Professional Memberships

Other Languages

  • Spanish

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: